Keywords: cortex, begins, ph, i/ii, ampalex, pharmaceuticals, collaboration

Cortex Begins Ph I/II With Ampalex

Article | 24 February 1997

Print This

Cortex Pharmaceuticals, in collaboration with the US National Institutesof Health, has begun patient enrollment for a Phase I/IIa trial ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in